Handbook of Experimental Pharmacology
© 2019
Antidepressants
From Biogenic Amines to New Mechanisms of Action
Editors: Macaluso, Matthew, Preskorn, Sheldon H. (Eds.)
Free Preview- Outlines the most up to date evidence regarding the treatment of depression
- Concise, yet comprehensive, in its review of clinical evidence
- Appeals to both clinicians and researchers alike
Buy this book
- About this book
-
This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.
- Table of contents (17 chapters)
-
-
Impact, Diagnosis, Phenomenology, and Biology
Pages 3-33
-
Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
Pages 37-48
-
Clinical Implications of the STAR*D Trial
Pages 51-99
-
Pharmacogenomics and Biomarkers of Depression
Pages 101-113
-
Therapeutic Drug Monitoring of Antidepressants
Pages 115-133
-
Table of contents (17 chapters)
Recommended for you
Bibliographic Information
- Bibliographic Information
-
- Book Title
- Antidepressants
- Book Subtitle
- From Biogenic Amines to New Mechanisms of Action
- Editors
-
- Matthew Macaluso
- Sheldon H. Preskorn
- Series Title
- Handbook of Experimental Pharmacology
- Series Volume
- 250
- Copyright
- 2019
- Publisher
- Springer International Publishing
- Copyright Holder
- Springer Nature Switzerland AG
- eBook ISBN
- 978-3-030-10949-3
- DOI
- 10.1007/978-3-030-10949-3
- Hardcover ISBN
- 978-3-030-10948-6
- Series ISSN
- 0171-2004
- Edition Number
- 1
- Number of Pages
- XII, 442
- Number of Illustrations
- 9 b/w illustrations, 8 illustrations in colour
- Topics
